PI3K-Akt-mTOR

The PI3K/AKT/mTOR signaling pathway is strongly involved in the fundamental cellular processes of protein synthesis and apoptosis, and disturbed activation of this intracellular pathway has been associated with the development of diseases such as cancer, diabetes mellitus, and autoimmunity[1]. Upon activation of  phosphatidylinositol (PI)-3-kinase (PI3K) by extracellular growth factors, phosphorylation of the inner membrane phosphoinositides activates AKT (also known as Protein Kinase B, PKB) and PDPK1 (3-phosphoinositide dependent protein kinase-1). In turn, mTOR (mammalian target of rapamycin)  is activated downstream, which plays an important role in cell cycle progression[2]. In many cancer cells, this PI3K/AKT/mTOR pathway is highly active, which can be the result of  amplification or mutation of the PI3-kinase gene; amplification or mutation of the Akt gene; or loss of function of PTEN (Phosphatase and tensin homolog). The latter normally regulates the removal of phosphate groups of the PI3K mediated phosphorylated membrane phospholipids, one of the regulating mechanisms to prevent over activations of this pathway.


[1] PI3K-Akt pathway: its functions and alterations in human cancer. Osaki M, Oshimura M, Ito H. Apoptosis 2004, 9, 667-676.
[2] PI3K/Akt/mTOR pathway as a target for cancer therapy. D. Morgensztern, H.L. McLeod Drugs 2005, 16, 797–803

Items 1 to 30 of 169 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Axon ID Name Description From price
1909 A 1070722 Selective inhibitor of GSK-3 €95.00
1831 A 66 PI3K inhibitor (p110-α specific) €95.00
1466 A 769662 AMPK activator €85.00
2857 Acalisib PI3K inhibitor (p110 δ specific) €120.00
3590 ACT001 PAI-1 inhibitor €210.00
2275 AdipoRon Orally active small-molecule AdipoR agonist €80.00
2389 AICAR Potent AMPK activator and inducer of differentiation of NSCs €45.00
2540 Akt Inhibitor VIII Inhibitor of Akt1 and 2 with significant off-side effects (CaMKIα and AhR) €95.00
2925 Alpelisib PI3K inhibitor (p110-α specific) €90.00
2368 Amuvatinib RTK inhibitor which effectively inhibits PDGFR, c-Kit and c-Met €105.00
3328 APIO-EE-07 Dual RSK1/MSK2 inhibitor €140.00
2167 AR-A 014418 ATP-competitive GSK-3 inhibitor €85.00
3041 ARN 3236 Potent, selective, ATP-competitive, and orally available inhibitor of SIK2 €95.00
1424 AS 252424 PI3K inhibitor (p110-γ specific) €85.00
1436 AS 252424 bispotassium salt PI3K inhibitor (p110-γ specific) €95.00
2166 AT 13148 dihydrochloride ATP-competitive inhibitor of multi-AGC kinases €70.00
2748 Autophinib PIK3C3/Vps34 inhibitor €120.00
5051 Axon Ligands™ Cell signaling and Oncology compound library Axon Ligands™ Cell signaling and Oncology compound library Inquire
5053 Axon Ligands™ Stem cell compound library Axon Ligands™ Stem cell compound library Inquire
2345 AZ 20 Potent, orally active and selective inhibitor of ATR protein kinase €105.00
2171 AZD 1080 Selective inhibitor of GSK-3α and GSK-3β €110.00
2194 AZD 2858 hydrochloride Potent and highly selective Glycogen Synthase Kinase-3β inhibitor €95.00
1859 AZD 5363 dihydrochloride Inhibitor of protein kinase B (Akt) €90.00
2926 AZD 6482 PI3K inhibitor (p110 β specific) €120.00
1561 AZD 8055 mTOR inhibitor €80.00
3134 AZD6738 Potent, selective, orally active and bioavailable ATR kinase inhibitor €110.00
3690 AZD8186 PI3Kβ/δ isoform-selective inhibitor Inquire
2981 B106 Potent and selective PKC-δ inhibitor €135.00
3055 B591 Potent, specific class I PI3K inhibitor €125.00
1282 BAG 956 PI3K and PDPK1 inhibitor €95.00

Items 1 to 30 of 169 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Please wait...